 1. To evaluate facial skin microbiota in participants with acne vulgaris at baseline, week 4, week 8, week 12, and week 16 in B244-treated participants compared to placebo from: i Skin swabs will be taken from forehead, nose, both cheeks and chin All participants placebo and B244 will undergo skin swabs and testing. 